Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.

Medicine - 1 Jul 2016

Younossi Zobair M, Stepanova Maria, Henry Linda, Nader Fatema, Younossi Youssef, Hunt Sharon

Abstract excerpt

Patients' experience during treatment may affect treatment adherence. Our aim was to assess the impact of patient-reported outcomes (PROs) on adherence to different anti-hepatitis C virus (HCV) regimens.Clinical, demographic, and PRO data (short form-36 [SF-36], chronic liver disease questionnaire-hepatitis C version [CLDQ-HCV], functional assessment of chronic illness therapy-fatigue [FACIT-F], work productivity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Clinical Trials, Phase III as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorenes

Share to Interferons

Share to Medication Adherence

Share to Multicenter Studies as Topic

Share to Patient Reported Outcome Measures

Share to Sofosbuvir

Source

Open in PubMed Open full text

Identifiers

PMID: 27428205
DOI: 10.1097/MD.0000000000004151
PMCID: PMC4956799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.PMID 27428205Read ↗

Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.Semantic proximity Read ↗

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Semantic proximity Read ↗

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.Semantic proximity Read ↗

The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life.Semantic proximity Read ↗

Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.Semantic proximity Read ↗

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.Semantic proximity Read ↗

Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.Semantic proximity Read ↗

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.Semantic proximity Read ↗

Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment.Semantic proximity Read ↗

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.Semantic proximity Read ↗

[Importance of medication adherence to peginterferon-ribavirin combination therapy in patients with chronic hepatitis C].Semantic proximity Read ↗

Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.